2',3'-dideoxy-beta-5-fluorocytidine has been researched along with zalcitabine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 9 (90.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchi, JJ; Driscoll, JS; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Shirasaka, T; Siddiqui, MA | 1 |
| Broder, S; Driscoll, JS; Kim, CH; Marquez, VE; Mitsuya, H | 1 |
| Cheng, YC; Dutschman, GE; Lin, TS; Liu, MC; Luo, MZ; Pai, SB | 2 |
| Cheng, YC; Liu, SH; Skalski, V | 1 |
| Ashman, C; Barbeau, D; Cammack, N; Duchaine, J; Gagnon, L; Hamel, M; Hooker, E; Jutras, D; Nordstrom, PA; Tse, A | 1 |
| Aubertin, AM; Bergogne, MC; Gosselin, G; Imbach, JL; Kirn, A; Mathé, C; Schinazi, RF; Sommadossi, JP | 2 |
| Borel, C; Cheng, YC; Dannaoui, E; Hantz, O; Lin, TS; Liu, SH; Trépo, C; Zoulim, F | 1 |
| Cretton-Scott, E; Gosselin, G; Imbach, JL; Martin, LT; Mathe, C; McClure, HM; Schinazi, RF; Sommadossi, JP; Zhou, XJ | 1 |
10 other study(ies) available for 2',3'-dideoxy-beta-5-fluorocytidine and zalcitabine
| Article | Year |
|---|---|
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Chemical Phenomena; Chemistry, Physical; Cytarabine; Cytidine Deaminase; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Stability; HIV-1; Hydrogen-Ion Concentration; Macaca mulatta; Molecular Structure; Structure-Activity Relationship; Zalcitabine | 1992 |
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemical Phenomena; Chemistry; Deoxycytidine; HIV; Structure-Activity Relationship; T-Lymphocytes, Helper-Inducer; Zalcitabine | 1987 |
Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Topics: Animals; Antiviral Agents; DNA, Mitochondrial; Hepatitis B virus; HIV-1; Humans; Leukemia L1210; Mice; Microbial Sensitivity Tests; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Zalcitabine | 1994 |
Removal of anti-human immunodeficiency virus 2',3'-dideoxynucleoside monophosphates from DNA by a novel human cytosolic 3'-->5' exonuclease.
Topics: Antiviral Agents; Base Sequence; Cell Line; Cytosol; Dideoxynucleosides; DNA, Single-Stranded; Exonucleases; HIV-1; Humans; Molecular Sequence Data; Phosphates; Stavudine; Stereoisomerism; Substrate Specificity; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Immunomodulatory and antiviral activities of 2',3'-dideoxy-beta-L-cytidine and 2',3'-dideoxy-beta-L-5-fluorocytidine.
Topics: Animals; Antiviral Agents; Cell Cycle; Cell Line; Chlorocebus aethiops; Hepatitis B virus; HIV; Humans; Immunosuppressive Agents; Lymphocyte Activation; Mice; Simplexvirus; T-Lymphocytes; Tumor Cells, Cultured; Vero Cells; Zalcitabine | 1995 |
Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures.
Topics: Cells, Cultured; HIV; HIV-1; HIV-2; Molecular Conformation; Stereoisomerism; Zalcitabine | 1994 |
Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.
Topics: Antiviral Agents; Bone Marrow; Cell Line; Drug Resistance; HIV; Humans; Stereoisomerism; Zalcitabine | 1994 |
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
Topics: Antiviral Agents; Cells, Cultured; DNA; Hepatitis B; Hepatitis B virus; HIV-1; Stereoisomerism; Virus Replication; Zalcitabine | 1994 |
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Topics: Animals; Antiviral Agents; Blotting, Southern; Cells, Cultured; DNA Replication; DNA, Viral; Ducks; Female; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Liver; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication; Zalcitabine | 1996 |
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
Topics: Animals; Anti-HIV Agents; Kinetics; Macaca mulatta; Metabolic Clearance Rate; Zalcitabine | 1999 |